NAM NGUYEN: Open Payments
NPI 1700570355 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,842 in 112 payments from 20 companies in 2025. Trend: 2023 $283 · 2024 $1,583 · 2025 $2,842
Food & beverage: $2,413Consulting: $350Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $409 |
| GlaxoSmithKline, LLC. | 19 | $348 |
| JAZZ PHARMACEUTICALS INC. | 6 | $292 |
| Verona Pharma, Inc. | 14 | $233 |
| Amgen Inc. | 14 | $226 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $216 |
| GENZYME CORPORATION | 9 | $200 |
| Regeneron Healthcare Solutions, Inc. | 8 | $151 |
| ALK-Abello, Inc | 5 | $114 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $111 |
Products named: DUPIXENT, XYWAV, TEZSPIRE, Ohtuvayre, LUMRYZ, AIRSUPRA, NUCALA, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
